Sudeep Pharma Limited (NSE:SUDEEPPHRM)

Market Cap	63.35B
Revenue (ttm)	5.61B
Net Income (ttm)	1.49B
Shares Out	112.95M
EPS (ttm)	13.77
PE Ratio	40.75
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	221,224
Average Volume	304,053
Open	541.60
Previous Close	541.60
Day's Range	541.60 - 572.95
52-Week Range	524.05 - 795.00
Beta	n/a
RSI	38.42
Earnings Date	Dec 19, 2025

About Sudeep Pharma

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-drie...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 480
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SUDEEPPHRM

Financial Performance

In 2024, Sudeep Pharma's revenue was 5.02 billion, an increase of 9.30% compared to the previous year's 4.59 billion. Earnings were 1.39 billion, an increase of 4.14%.